Radius Health
+$0.22 (+3.67%) As of 6:37 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Radius Health and other ETFs, options, and stocks.
About RDUS
Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis.
CEO
George Kelly Martin
Employees
293
Headquarters
Boston, Massachusetts
Founded
2003
RDUS Key Statistics
Market cap
295.89M
Price-Earnings ratio
—
Dividend yield
—
Average volume
989.60K
High today
$6.24
Low today
$6.02
Open price
$6.03
Volume
222.37K
52 Week high
$23.00
52 Week low
$4.97
RDUS News
Analyst ratings
71%
of 7 ratings
Buy
0%
Hold
71.4%
Sell
28.6%
RDUS Earnings
-$0.42
-$0.23
-$0.04
$0.15
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market